...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AGM - High Level Summary
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Hi fouremm.

Thanks for this. I'm not too good at understanding the share structure. So let's say, for example, I own 50,000 Zenith shares pre-reorg. So after the reorg I own 50,000 shares of ZCC. So let's say that Zenith epigenetics goes public with ZEN3694 then I will own 50,000 share of this new public company and I will still own 50,000 in ZCC?????

Does that sound right?

Thanks

Toinv

1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply